Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Oncology
Clinical Trials: Sezary Syndrome
A listing of clinical trials currently looking for volunteers to enroll in Sezary Syndrome studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama at Birmingham
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
California
Stanford : Stanford University School of Medicine
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Stanford : Stanford University Medical Center
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Louisiana
New Orleans : Tulane University Health Science Center
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
New York
New York : New York Medical Center
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Ohio
Columbus : Ohio State University Medical Center
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Pennsylvania
Philadelphia : University of Pennsylvania Health System
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Pittsburgh : University of Pittsburgh School of Medicine
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Texas
Houston : MD Anderson Cancer Center
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Houston : MD Anderson Cancer Center
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Japan
Isehara : *
E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma
